Will possibly rise to $1 this yr given Avant Diagnostics team is sharp
Will possibly rise to $1 this yr given Avant Diagnostics team is sharp and has for the first time shown more of realistic and stated goals. Question remains how succesful they will be at securing the funding for OvaDx and in filing of FDA application on time.
I would like to see a nice strategic partnership or licensing/marketing deal with some upfront fees and the partner picking up development costs. If OvaDx is so great why can't they find a larger life sciences or diagnostics firm interested?
I also would like to see Mark Schena stop his childish stupid non stop pumping about ARYC stock. Just focus on increasing sales and profits. Once investors see that it will make stock price rise. No need to hype daily.
If this management plays its cards well this stock does have potential to be $1 to $3 in 2013 imho
I still don't have any faith in Mark Schena or Rene Schena but the team at Avant Diagnostics seem sharp. We have to see how well they could execute and keep promises achieving the goals. If they could form stratgeic relationship for OvaDx, secure new funding, file application with FDA and initiate clinical trials on time this stock will slowly rise to $1 imho